Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.

The article presents a case study of a 52-years-old male patient diagnosed with acute myeloid leukemia with normal karyotype. Topics discussed include development of resistance to drugs such as citarabine and etoposide, development of polycythemiaduring iron chelating therapy (ICT) in the patient after allogeneic hematopoietic progenitor cell transplantation (allo-HPCT), and association of polycythemia with erytheroid.